ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

The Tivozanib Timeline

May 10, 2013

RAC Grumbles, Gives Healy Guidelines For Compassionate Use Of Gene Therapy

January 22, 1993

New Law Allows Texans To Self-Refer To M.D. Anderson

December 1, 1995

Cancer Mmeetings Lister For Next Three Months

February 23, 1996

NCI-Approved Clinical Trials Listed For April 2001

May 25, 2001

Yarbro Leaves Centers Program With Pitch for More Money for Core Grants, Community Outreach, Control

July 18, 1975